| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ASPG
|
asparaginase
|
|
ASRGL1
|
asparaginase like 1
|
|
ATN1
|
atrophin 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
CCND2
|
cyclin D2
|
|
CD19
|
CD19 molecule
|
|
CD22
|
CD22 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CNTNAP1
|
contactin associated protein 1
|
|
CPQ
|
carboxypeptidase Q
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
EDN1
|
endothelin 1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EVPL
|
envoplakin
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA13
|
interferon, alpha 13
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
JAK2
|
Janus kinase 2
|
|
KRT20
|
keratin 20, type I
|
|
LBR
|
lamin B receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
PGF
|
placental growth factor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PML
|
promyelocytic leukemia
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PTEN
|
phosphatase and tensin homolog
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RB1
|
retinoblastoma 1
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
SCT
|
secretin
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
